Trial intelligence / Profile preview

CPP-ACP FV vs Fluoride Varnish for White Spot Lesions in Primary Teeth

NCT03865680Phase 2Completed

Start
Apr 2019
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of MI Varnish in White spot lesion (WSL) (2 arms). Primary endpoints: Oral Hygiene Index-Simplified at 30 weeks, Visio-tactile evaluation of the white spot lesion at 30 weeks and 1 more. Started Apr 2019; status: completed.

02

Drugs

MI Varnish
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT03865680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03865680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call